May 2nd 2025, 8:00pm
Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of participating in a clinical trial.
May 2nd 2025, 7:00pm
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
May 2nd 2025, 5:00pm
After testicular cancer, I’ve learned to guard my mood, seek small joys and embrace healing and renewal with every sunrise this spring.
May 2nd 2025, 4:00pm
The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.
May 2nd 2025, 3:00pm
New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.
May 2nd 2025, 1:00pm
Enrollment and initial dosing of PAS-004 at 30 milligrams has begun in three patients with MAPK pathway-driven advanced solid tumors.
May 1st 2025, 9:00pm
Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types.
May 1st 2025, 8:09pm
Breast cancer treatment is a physical, emotional, and mental challenge. Facing cancer and its side effects demands extraordinary physical, emotional, and spiritual stamina.
May 1st 2025, 8:00pm
Dr. Neha Mehta-Shah discusses ways patients with rare blood cancers, such as lymphoma, can better understand their specific subtype of disease.
May 1st 2025, 7:53pm
Triage Health offers free, expert-led education on the legal and practical issues that impact individuals coping with chronic or serious medical conditions.
Finally Learning to Put Myself First
Experts Discuss Next Steps in Perioperative Bladder Cancer Treatment
Signatera Guides Bladder Cancer Treatment After Surgery
What If? Embracing Hope During a Cancer Journey